Elwyn Pharmacy Group

9
Nov

BioMatrix Family of Companies Expands with Acquisition of Elwyn Pharmacy Group

Purchase Doubles Company Size And Adds Therapeutic Categories To Portfolio Of Services

[Download PDF]

Weston, FL – November 8, 2017 – BioMatrix SpRx, a growing leader in the specialty pharmacy industry, today announced the acquisition of Elwyn Pharmacy Group in Garnet Valley, Pennsylvania, 30 miles southwest of Philadelphia.

BioMatrix offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. The growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. BioMatrix excels in providing services for hemophilia and bleeding disorders, transplant therapy, IVIg and specialty care, and digital health technology.

Elwyn Pharmacy Group provides medications and supportive services for patients living with hard to treat disease states with the goal of achieving optimal patient outcomes. This is realized through compliance and individualized therapy management in an environment that maximizes patient satisfaction and adherence. Elwyn’s expertise in neurological and auto-immune disorders, fertility, oncology, and other chronic conditions has made them a leader in the specialty pharmacy industry.

As a result of this transaction, BioMatrix has expanded their services into complementary therapeutic categories requiring the same high-touch services they are accustomed to providing. BioMatrix’s national footprint increases to 11 pharmacy locations, nationwide, in key metropolitan locations. Elwyn joins the rapidly growing family of companies that comprise

BioMatrix including Matrix Health Group, Factor Support Network, Medex BioCare, and BiologicTx.

“The acquisition of Elwyn Pharmacy Group complements our strategy of bringing together leaders in the specialty pharmacy industry to provide comprehensive, compassionate care to patients living with complex, chronic diseases, “stated Bruce Greenberg, Chief Executive Officer, BioMatrix SpRx. “We are pleased to welcome Elwyn and their experienced staff to the BioMatrix family.”

“BioMatrix and Elwyn share very similar values. The success of both companies is rooted in our collaborative, compassionate patient-centered approach,” stated Nicholas Karalis, Chief Executive Officer, Elwyn Pharmacy Group. “Together, we expand our ability to provide a high level of individualized, focused care to patients living with a chronic condition. We are extremely excited to be part of this larger organization.”

Additional information on BioMatrix and Elwyn can be found at www.biomatrixsprx.com and www.elwynspecialtycare.com, respectively.

About BioMatrix SpRx

BioMatrix SpRx, a portfolio company of Acon Investments and Triton Pacific Capital Partners, LLC., offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes Matrix Health GroupFactor Support NetworkMedex BioCareBiologicTx.

About Elwyn Pharmacy Group

Elwyn Pharmacy Group provides a complete range of specialty pharmacy and infusion services. We treat a wide array of complex disease states such as Multiple Sclerosis, Hepatitis C and other GI related diseases, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis and HIV. The Elwyn Pharmacy Group includes Elwyn PharmacyGlen Rock Medical PharmacyElwyn Specialty Care, and Med Center Specialty Pharmacy.

21
Jul

Elwyn Pharmacy Group announces the addition of Scott Ringer as National Director of Business Development – Fertility

We are very pleased to announce the appointment of Scott Ringer as National Director of Business Development Fertility.

Scott comes to Elwyn Pharmacy Group with 16 years of knowledge and experience in his field.  Scott began his career in Reproductive Health working in Specialty pharmacy.  He has expertise in Specialty Infusion with a focus on Fertility medications.  He began his career as a nurse and an IVF patient himself.  Not only does he come to Elwyn with firsthand patient experience, he also has expertise in physician, pharmacy interactions and IVF protocols and medications.

After 13 years as a Reproductive Specialist with Ferring Pharmaceuticals, we welcome Scott to Elwyn Pharmacy Group.  His mission is to assist Glen Rock Medical Pharmacy to be number one in patient care while expanding to a national presence.  Scott has 4 children and two grandchildren and volunteers his time as a flight nurse for Cincinnati Children’s Hospital.

Please join us in welcoming Scott to the Elwyn family!

21
Jul

Elwyn Pharmacy Group announces the addition of Mala Crossley, PharmD as Vice President of Payer Relations

Please join us in welcoming Mala Crossley to the Elwyn family. Mala Crossley, PharmD, is a recognized leader in the development of patient outcomes data for health insurance companies. Combined with her recent experience as Senior Director of Business Development at CareCentrix, a corporation that manages payer, provider, and patient care, she is uniquely qualified to be Elwyn’s Vice President of Payer Relations.

Over the last 15 years, Mala has worked in Specialty, Home Infusion, and Long Term Care Pharmacy, rising to National Director, Clinical Operations for BioScrip. She has history of successfully executing complex programs that require drive, commitment and excellent interpersonal skills, as well as an extensive knowledge of pharmacy services.

Mala and her family reside in Cincinnati, Ohio, but she claims New York as her home. Please join us in wishing Mala a warm welcome to Elwyn Pharmacy Group.

21
Jul

Elwyn Pharmacy Group announces the addition of Mario Patone as Chief Financial Officer

We are very excited to welcome Mario Patone to the Elwyn family. Mario brings over 25 years of expertise to his role as Chief Financial Officer of Elwyn Pharmacy Group. Prior to joining Elwyn, Mario served as CFO for an international durable medical equipment manufacturer. Before working in the private sector, Mario was the partner in charge of Transaction Advisory Services for a top ten national CPA and consulting firm.

Mario’s experience includes working with business owners to help identify key finance and operational issues and providing in-depth analyses, enabling shareholders to gain a clearer understanding of their organization. He has worked primarily with privately held entrepreneurial businesses, public corporations and small to mega private equity funds.  In addition to due diligence, Mario has an extensive background with financial statement auditing, modeling, forecasts and data mining to assist businesses with post-deal integration projects, investigative transactional analysis, inventory utilization and working capital disputes.

Mario has managed a wide variety of service offerings, including accounting, auditing, transaction advisory services, and other assurance services on behalf of clients throughout the Americas and Europe. Additionally, Mario was a principal contributor and co-author of COSO’s “Internal Control Over Financial Reporting – Guidance for Smaller Public Companies”.

Mario is also an active member of his local community, volunteering time to religious and not-for-profit organizations.

Please join us in welcoming Mario to the Elwyn family!

23
Feb

Elwyn Pharmacy Group announces the addition of Marc Stranz PharmD as Vice President of Compliance

Elwyn Pharmacy Group is excited to announce the addition of Marc Stranz PharmD as Vice President of Compliance. Marc has worked for more than 30 years in sterile pharmacy compounding and was an early leader in the home infusion industry. He has held branch, regional, and corporate positions with several national providers, including Senior Vice President for Clinical and Strategic Operations at Coram and Vice President of Clinical Operations and Regulatory Affairs at BioScrip. He was also Corporate Director of Infusion Services for Omnicare and Chief Clinical Officer for BioScrip Specialty Services.

A recognized business leader and subject matter expert, his work is part of the core practice standards of the industry established by professional organizations and regulatory bodies as well as the body of policy and procedure used by home infusion organizations. Dr Stranz pioneered safe and efficient provision of advanced infusion therapies in home infusion and has sustained involvement in cutting-edge therapies. His expertise includes clinical and operational services, regulatory compliance, accreditation, sterile compounding, and design/build of cleanrooms and infusion facilities. He served on the USP Expert Panel for Sterile Compounding, the Board of Pharmaceutical Specialties Practice Analysis Taskforce in Sterile Compounding, and the Institute of Environmental Sciences and Technology (IEST) Working Group for Controlled Environments per USP Chapter 797

1
Feb

Elwyn Pharmacy Group Earns URAC Accreditation at Three Locations

Accreditation by URAC demonstrates Elwyn Pharmacy Group’s ongoing commitment to the highest level of quality as a multi-location specialty pharmacy serving patients, prescribers, and payers.

Elwyn Pharmacy Group, announces today that URAC, the largest accrediting body for health care, has given its seal of approval by accrediting it through a rigorous on-site process at three of EPG’s location simultaneously ( Elwyn Specialty Care, Med Center Specialty Pharmacy and Glen Rock Medical Pharmacy). This most recent accreditation from URAC adds to a prestigious list of accreditations that EPG already maintains, including accreditations from ACHC and PCAB.

It is an honor to achieve full URAC accreditation at three of our specialty pharmacy locations.  This accreditation displays our commitment to quality and excellence in providing the highest level of customer service possible to our patients and referral sources.  We are so proud of our EPG team members for their hard work and dedication to our mission which made this monumental task a reality (“Our goal is to achieve optimal patient outcomes through compliance and delivery of individualized medication therapy management in an environment that maximizes patient satisfaction and adherence”) says Nicholas Karalis, RPh, President CEO at Elwyn Pharmacy Group

URAC, the industry leader for health care accreditation, is an independent, nonprofit organization that provides benchmarking services throughout the health care system. The URAC accreditation process included a review of all EPG policies and procedures as well as an onsite visit to confirm that the operations at EPG do, in fact, conform to all documented submitted policies and procedures. A committee of health care experts developed the URAC standards, which are updated every three years.

Since URAC is independent accrediting body patients, referral sources as well as other customers can feel confident that the accreditation process is impartial and not influenced by any other outside industry interests. Accreditation from URAC serves as a symbol of excellence and demonstrates to patients, providers, and insurance payers that EPG as an independently owned and operated company is committed to operating at strict quality standards.

About Elwyn Pharmacy Group
At Elwyn Pharmacy Group we provide medications, under a comprehensive umbrella of medication therapy management, to people living with many complex disease states. We understand the complexity of managing patients’ medication and that treatment paradigms vary greatly and are highly individualized. Our patient-centered approach enables us to adapt and customize a collaborative medication therapy management plan for every patient.  It is our goal to ensure treatment success and patient safety with the highest level of focus, care and compassion possible.

Elwyn Pharmacy Group provides a complete range of specialty pharmacy and infusion services.   We treat a wide array of complex disease states such as Hepatitis C, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis. Elwyn Pharmacy Group, a privately-held, pharmacist-owned company headquartered in Garnet Valley Pennsylvania, is accredited by URAC, PCAB, and the Accreditation Commission for Health Care (ACHC). For more information about Elwyn Pharmacy Group please contact us at 1-855-ELWYN-RX (359-9679) or visit us on the web at www.elwynpharmacygroup.com